DM

Damjibhai Manabhai Chhotala

Active Director Designated Partner DIN 11398503
DIN 11398503 First appointment Nov 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Damjibhai Manabhai Chhotala

Data last updated:

Damjibhai Manabhai Chhotala is a Designated Partner at Sadvichar General Hospital Palitana Llp (since 2025).

DIN 11398503
Primary Designation Designated Partner
First Appointment 27 Nov 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner27 Nov 20252025Active

Board colleagues of Damjibhai Manabhai Chhotala

Directorship timeline

Open interactive timeline →
Sadvichar General Hospital Palitana Llp
Premium access

Shareholding and investment profile for Damjibhai Manabhai Chhotala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Damjibhai Manabhai Chhotala

Damjibhai Manabhai Chhotala currently holds 1 directorship: Sadvichar General Hospital Palitana Llp (Designated Partner, since 27 Nov 2025).

Damjibhai Manabhai Chhotala was first appointed on 27 Nov 2025 as Designated Partner at Sadvichar General Hospital Palitana Llp.

The current boards of Damjibhai Manabhai Chhotala's companies include Arvindbhai Pujabhai Vala (Sadvichar General Hospital Palitana Llp), Ganpatbhai Ravgibhai Baldaniya (Sadvichar General Hospital Palitana Llp), Ghanshyambhai Sondabhai Chhotala (Sadvichar General Hospital Palitana Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available